ESC 365 - Efficacy of sodium glucose cotransporter 2 inhibitors for heart failure with preserved and mildly reduced ejection fraction: a systematic review and meta-analysis

ESC Professional Premium Access

Efficacy of sodium glucose cotransporter 2 inhibitors for heart failure with preserved and mildly reduced ejection fraction: a systematic review and meta-analysis

Session: Poster Session 1

Topic: Treatment

Speaker: Doctor K. Rivera (Manila, PH)

Event: ESC Asia 2022 with APSC & AFC

Congress Presentation

Add to my library

About the speaker

Doctor Kathleen Rivera

Philippine Heart Center, Manila (Philippines)

0 follower

27 more presentations in this session

Frequent need for apixaban dose adjustment for atrial fibrillation in an unselected acute medical admission population during the COVID 19 pandemic.

Speaker: Doctor K. Kyaw (Plymouth, GB)

The use of hatch score for the prediction of post operative atrial fibrillation (poaf) after coronary artery bypass graft: a meta-analysis

Speaker: Doctor A. Ramos (Muntinlupa, PH)

Relationship and outcomes between volume status, cardiac and renal dysfunction in patients with chronic heart failure.

Speaker: Doctor A. Challa (Rochester, US)

Association between triglyceride and all-cause mortality and cardiovascular outcomes in heart failure patients: a territory-wide study in Hong Kong

Speaker: Mrs Q. Ren (CN)

Effects of SGLT2 inhibitors on heart failure symptoms, quality of life and exercise capacity in patients with heart failure and preserved ejection fraction: A meta-analysis

Speaker: Doctor L. Merin (Cebu City, PH)

Access the full session

Poster Session 1

Speakers: Doctor K. Rivera, Doctor K. Kyaw, Doctor A. Ramos, Doctor A. Challa, Mrs Q. Ren...

About the event

ESC Asia 2022 with APSC & AFC

1 December - 3 December 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources